Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides
Open Access
- 30 June 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 80 (6) , 1093-1097
- https://doi.org/10.1016/0002-9343(86)90670-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cefotaxime Compared with Nafcillin Plus Tobramycin for Serious Bacterial InfectionsAnnals of Internal Medicine, 1984
- Risk Factors for Nephrotoxicity in Patients Treated with AminoglycosidesAnnals of Internal Medicine, 1984
- Renal Kallikrein Excretion in Cirrhotics with Ascites: Relationship to Renal Hemodynamics†Hepatology, 1984
- Risk Factors for the Development of Auditory Toxicity in Patients Receiving AminoglycosidesThe Journal of Infectious Diseases, 1983
- Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: Evidence for increased vasoconstrictor and decreased vasodilator factorsGastroenterology, 1983
- Characterization of the renin-aldosterone system in decompensated cirrhosis.Circulation Research, 1977
- BIAS DUE TO MISCLASSIFICATION IN THE ESTIMATION OF RELATIVE RISKAmerican Journal of Epidemiology, 1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Gentamicin Therapy in Renal Failure: A Nomogram for DosageAnnals of Internal Medicine, 1972
- Pathophysiology of endotoxin shock in the primateAmerican Journal of Obstetrics and Gynecology, 1970